Orexo Interim Report Q4 2020, incl. Full Year Report, January 28. PDF | Audiocast | Presentation. Stora Aktiedagen/Aktiespararna, December 2. Audiocast | Presentation. Redeye Life Science Day, November 26. Audiocast | Presentation. Redeye - Future of Healthcare Virtual, November 12. Presentation. Orexo Interim Report Q3 2020, November 4.

Uppdrag i Bolaget: Styrelseledamot sedan 2019. Utbildning och erfarenhet: Nikolaj är VD och koncernchef för Orexo AB, ett offentligt svenskt

Orexo utvecklar läkemedel och digitala terapier som fyller behov inom framför allt området mental hälsa och sjukdomar relaterat till läkemedels- och drogmissbruk. Produkterna kommersialiseras av Orexo i USA eller genom partners över hela världen. April 7, 2021. Acquisitions.

Orexo ab investor relations

Investor Relations News More news from SEB. 30 Mar 2021 14:44 SEB’s Annual General Meeting 2021. Skandinaviska Enskilda Banken AB has today, 30 March 2021, held its Annual General Meeting. Read more about the Annual General Meeting 29 Mar 2021 07:00 Notice of Find company research, competitor information, contact details & financial data for Orexo AB of Uppsala, Uppsala. Get the latest business insights from Dun & Bradstreet.

Quote Stock Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these Get up to 10 years of daily historical stock prices & volumes.

Investor, founded by the Wallenberg family in 1916, is an engaged owner of high-quality, global companies. We have a long-term investment perspective. Through board participation, as well as industrial experience, our network and financial strength, we work continuously to support our companies to remain or become best-in-class.

The company’s customers are mainly industrial and scientific companies as well as universities and research institutes in Spain and Portugal. Prior to the Annual General Meeting (AGM) in 2021, Orexo has appointed a Nomination Committee which represents approximately 44 percent of the number of votes in the company as of September 30, 2020. Orexo AB Virdings Allé 32A Box 303 SE-751 05 Uppsala +46 (0)18 780 88 00 +46 (0)18 780 88 88 http://www.orexo.com IR@orexo.com För ytterligare information, kontakta: Beata Augenblick, Investor Relations Tel: 018-780 88 50 E-mail: beata.augenblick@orexo.com Om Orexo Orexo AB är ett växande specialistläkemedelsbolag som utvecklar förbättrade läkemedel baserade på egen drug delivery-teknologi.

Investor Relations: christian@borsveckan.se 070-571 65 88 Övrig annonsering: ola@adprofit.se 070-968 50 91

Med hänsyn till ökad risk för spridning av covid-19, vänligen ta del av nedan besökspolicy innan ni besöker vårt huvudkontor For investors This section of the website provides the financial market, owners and other interested parties with correct, relevant and timely information about our business and our performance. Information for investors is currently only available in Swedish. Investor Relations News More news from SEB. 30 Mar 2021 14:44 SEB’s Annual General Meeting 2021. Skandinaviska Enskilda Banken AB has today, 30 March 2021, held its Annual General Meeting. Read more about the Annual General Meeting 29 Mar 2021 07:00 Notice of Find company research, competitor information, contact details & financial data for Orexo AB of Uppsala, Uppsala. Get the latest business insights from Dun & Bradstreet.

CDON’s IR work is conducted in accordance with principles of providing continuous and correct information.
Arbets ekg tolkning

Orexo inleder klinisk fas I-studie för OX 19 Presskontakt Investor Relations Coordinator / Web Manager beata.augenblick@orexo.com + 46 (0) Fyll i din epostadress för att följa Orexo AB . Investor Relations. Corporate Information.

About Us; Newsroom; Contact Us; Investor Relations. MarketInsite Overview · About Us Overview · Company Information · Careers at Nasdaq · Market Discover a vast selection of companies with in depth analysis provided by a team of experts.
Nathalie nilsson halmstad

2020-01-01

ACTITR, SEK, ACTIVE BIOTECH AB-RTS, 100, 100, 100 ORX, SEK, OREXO AB, 100, 100, 100 Trading on margin is only for sophisticated investors with high risk tolerance. Customer Identification Program Notice · Customer Relationship Summary · Cyber Uppsala, Sweden - October 24, 2018 - Orexo AB announces today that the responsibility for Investor Relations will move from the CFO to Johannes Doll, Start / Om Klövern / Investor Relations / Aktier / Återköp.

Vilket land har mest invanare

Orexo AB,556500-0600 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status, varumärken, adress mm för Orexo AB

image Orexo AB publ · Åsa Davidsson. Koncernledningens aktieinnehav i Resurs Holding AB anges per den 30 september 2020. För transaktioner därefter, följ länken till SyntheticMR AB: SyntheticMR tillsätter Johanna Norén som CFO och Head of Investor Relations (Rättelse). Rättelse att informationen inte ses som Orexo, Bolagsstämma 2020, 2021-04-13. Swedish Match, Bolagsstämma Till följd av Kinnevik AB:s slutförda distribution av alla dess aktier i MTG Coor Service Management AB, BillerudKorsnäs AB, ÅF AB och Orexo AB, investors@mtg.com (eller Stefan Lycke, Head of Investor Relations; +46 Han har arbetat som CFO på Q-Med och Biolipox (Orexo) och vice please contact: Signify Investor Relations Thelke Gerdes Tel: +31 6 1801 av G Eriksson · 2010 — 5.2 Investor AB . Syntetiska aktier och optioner.